This provider's $364.9M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 2319% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 253% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $950.00 | $878.34 | 1.08x | $71.66 | $3.0M | 3.4K | 2 |
| 2017 | $1.2K | $822.43 | 1.49x | $401.73 | $10.4M | 12.7K | 7 |
| 2018 | $953.69 | $788.31 | 1.21x | $165.38 | $35.3M | 44.8K | 13 |
| 2019 | $1.1K | $989.47 | 1.12x | $118.78 | $56.5M | 57.1K | 15 |
| 2020 | $1.2K | $1.1K | 1.14x | $152.02 | $52.3M | 48.7K | 14 |
| 2021 | $1.6K | $1.4K | 1.13x | $189.80 | $69.0M | 48.4K | 16 |
| 2022 | $1.8K | $1.5K | 1.16x | $236.83 | $67.0M | 44.2K | 18 |
| 2023 | $1.8K | $1.5K | 1.19x | $285.63 | $71.4M | 47.3K | 8 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81479 | Molecular pathology procedure | 103.0K | $156.6M | $1.5K | 1.31x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 66.5K | $122.5M | $1.8K | 1.01x |
| 81432 | Test for detecting genes associated with inherited breast cancer-related disorders | 56.0K | $43.8M | $782.65 | 1.16x |
| 81433 | Gene analysis (breast and related cancers), duplication or deletion variants | 44.8K | $22.1M | $492.63 | 1.05x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 12.4K | $7.4M | $591.48 | 1.01x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 6.5K | $4.8M | $731.10 | 1.36x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 2.7K | $1.8M | $658.45 | 1.02x |
| 81292 | Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis | 2.6K | $1.7M | $655.33 | 1.02x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 2.5K | $1.6M | $619.64 | 1.02x |
| 81405 | Molecular pathology procedure level 6 genetic analysis | 3.4K | $1.0M | $299.01 | 1.01x |
| 81404 | Molecular pathology procedure level 5 | 3.5K | $953.0K | $271.20 | 1.02x |
| 81406 | Molecular pathology procedure level 7 | 1.5K | $415.0K | $277.80 | 1.02x |
| 81436 | Test for detecting genes associated with colon cancer, duplication/deletion analysis panel, at least 5 genes | 160 | $108.5K | $678.29 | 1.14x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 93 | $71.4K | $767.61 | 1.02x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 105 | $47.1K | $448.42 | 1.01x |
| 81448 | Gene analysis panel for hereditary disorders of the peripheral nervous system | 42 | $29.7K | $707.66 | 1.62x |
| 81408 | Molecular pathology procedure level 9 | 12 | $23.7K | $2.0K | 1.01x |
| 81295 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 100 | $22.3K | $223.33 | 1.36x |
| 81232 | Gene analysis (dihydropyrimidine dehydrogenase) for common variant | 103 | $17.9K | $173.84 | 1.01x |
| 81335 | Gene analysis (thiopurine s-methyltransferase) for common variant | 97 | $16.9K | $173.82 | 1.01x |
This provider submits charges 1.16 times higher than what Medicare actually pays.
A markup ratio of 1.16x means for every $100 Medicare pays, this provider initially charges $116. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data